DOI QR코드

DOI QR Code

Femoropopliteal Artery Stent Fracture with Recurrent In-Stent Reocclusion and Aneurysm Formation: Successful Treatment with Self-Expandable Viabahn Endoprosthesis

  • Lee, Yong-Joon (Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Shin, Dong-Ho (Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Kim, Jung-Sun (Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Kim, Byeong-Keuk (Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Ko, Young-Guk (Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Hong, Myeong-Ki (Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Jang, Yangsoo (Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Choi, Donghoon (Severance Cardiovascular Hospital, Yonsei University Health System)
  • Received : 2014.12.30
  • Accepted : 2015.04.02
  • Published : 2015.11.30

Abstract

Primary stenting in femoropopliteal lesions of intermediate length has recently shown favorable outcomes. However, stent fractures are a concern after bare metal stent implantation. The incidence of stent fracture varies widely (ranging from 2% to 65%) depending on factors such as the treated lesions or stent type and may potentially lead to various complications. We reported a case of stent fracture with complete dislocation combined with recurrent in-stent reocclusion and aneurysm formation in a patient with occlusive disease of the femoropopliteal artery, which was successfully treated with self-expandable endovascular stent graft.

Keywords

References

  1. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-9. https://doi.org/10.1161/CIRCULATIONAHA.107.688341
  2. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007;116:285-92. https://doi.org/10.1161/CIRCULATIONAHA.107.689141
  3. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-76. https://doi.org/10.1161/CIRCINTERVENTIONS.109.903468
  4. Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL. The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg 2008;36:339-45. https://doi.org/10.1016/j.ejvs.2008.05.005
  5. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Nagata S. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4 years. JACC Cardiovasc Interv 2009;2: 665-71. https://doi.org/10.1016/j.jcin.2009.04.014
  6. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 2005;12:6-12. https://doi.org/10.1583/04-1359.1
  7. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5. https://doi.org/10.1016/j.jacc.2004.11.026
  8. European Stroke Organisation, Tendera M, Aboyans V, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-906. https://doi.org/10.1093/eurheartj/ehr211
  9. Nikanorov A, Smouse HB, Osman K, Bialas M, Shrivastava S, Schwartz LB. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions. J Vasc Surg 2008;48:435-40. https://doi.org/10.1016/j.jvs.2008.02.029
  10. Babalik E, Gülbaran M, Gürmen T, Oztürk S. Fracture of popliteal artery stents. Circ J 2003;67:643-5. https://doi.org/10.1253/circj.67.643
  11. Okamura T, Hiro T, Fujii T, et al. Late giant coronary aneurysm associated with a fracture of sirolimus eluting stent: a case report. J Cardiol 2008;51:74-9. https://doi.org/10.1016/j.jjcc.2007.11.002
  12. Solis J, Allaqaband S, Bajwa T. A case of popliteal stent fracture with pseudoaneurysm formation. Catheter Cardiovasc Interv 2006;67: 319-22. https://doi.org/10.1002/ccd.20600
  13. Tsuji Y, Kitano I, Iida O, Kajita S, Sawada K, Nanto S. Popliteal pseudoaneurysm caused by stent fracture. Ann Vasc Surg 2011;25:840.e5-8.
  14. Rivolta N, Fontana F, Piffaretti G, Tozzi M, Carrafiello G. A case of late femoral pseudoaneurysm caused by stent disconnection. Cardiovasc Intervent Radiol 2010;33:1036-9. https://doi.org/10.1007/s00270-009-9677-5

Cited by

  1. Development of a New Hybrid Biodegradable Drug-Eluting Stent for the Treatment of Peripheral Artery Disease vol.2016, pp.None, 2015, https://doi.org/10.1155/2016/6915789
  2. Endovascular repair of popliteal artery aneurysms: an Italian multicenter study vol.124, pp.1, 2015, https://doi.org/10.1007/s11547-018-0941-0